Related Experiment Video
Updated: Sep 14, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Cardiac magnetic resonance imaging in Fabry disease
Hatty Hoi Ting Chau1, Wai Yuk Fung1, Johnny Ka Fai Ma1
1Department of Radiology, Princess Margaret Hospital, Kowloon, Hong Kong.
Insights
Fabry disease (FD) is a rare genetic disorder affecting the heart. Cardiac MRI is crucial for diagnosing FD cardiomyopathy, enabling early detection and guiding enzyme replacement therapy.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Background:
- Fabry disease (FD) is a rare X-linked lysosomal storage disorder.
- Cardiac involvement is common in FD, often presenting as left ventricular hypertrophy.
- Differentiating FD cardiomyopathy from other hypertrophic conditions can be difficult, particularly without extracardiac signs.
Purpose of the Study:
- To review the characteristic cardiac MRI features of Fabry disease cardiomyopathy.
- To improve awareness of FD among clinicians managing unexplained cardiomyopathies.
- To emphasize the role of cardiac MRI in early detection and monitoring of FD.
Main Methods:
- Review of existing literature and imaging studies on Fabry disease cardiomyopathy.
- Focus on characteristic findings in cardiac magnetic resonance imaging (MRI).
- Analysis of how MRI aids in quantitative and qualitative assessment of cardiac involvement.
Main Results:
- Cardiac MRI is essential for assessing FD cardiomyopathy.
- MRI can detect subclinical cardiac phenotypes and monitor disease progression.
- Characteristic imaging features help distinguish FD cardiomyopathy.
Conclusions:
- Cardiac MRI is vital for diagnosing and managing Fabry disease cardiomyopathy.
- Early detection through MRI facilitates timely enzyme replacement therapy.
- Increased awareness of FD's cardiac manifestations is needed for improved patient outcomes.
Abstract:
Fabry disease (FD) is a rare X-linked lysosomal storage disorder. Cardiac involvement is frequent in the classic phenotype and late-onset cardiac variant of FD. It is challenging to distinguish FD cardiomyopathy from other forms of unexplained left ventricular hypertrophy, especially in those patients without extracardiac manifestations. Cardiac magnetic resonance imaging is an essential imaging modality for the quantitative and qualitative assessment of FD cardiomyopathy. It helps to monitor disease progress and allows early disease detection in the mild form or subclinical cardiac phenotypes. This review illustrates the characteristic imaging features of FD cardiomyopathy in cardiac MRI, aiming to enhance the awareness of this disease entity among the scope of unexplained cardiomyopathy and promote timely enzyme replacement therapy for patients.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Magnetic Resonance Imaging
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT

